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Abstract.  The protective function of skin depends on 
successful completion of a tightly regulated multi-step 
differentiation program,  during  which the induction of 
markers for a  specific stage in epidermal differentia- 
tion is coupled to repression of markers expressed at 
the preceding stage.  We have explored the role of pro- 
tein kinase C  (PKC) in this process using an in vitro 
model system, in which cultures of primary mouse 
epidermal keratinocytes are induced to terminally dif- 
ferentiate by raising the Ca  2§ concentration in the me- 
dium from 0.05  to 0.12  mM.  At doses which activate 
PKC,  12-O-tetradecanoylphorbol-13-acetate (TPA) and 
1-oleoyl-2-acetylglycerol block Ca2+-mediated  induction 
of the spinous cell markers keratins K1 and K10 at 
both the protein and mRNA level.  TPA and  1-oleoyl-2- 
acetylglycerol also rapidly repress K1 and K10 mRNA 
expression when added to differentiating keratinocyte 
cultures already expressing these markers.  The inhibi- 
tion of K1 mRNA expression by TPA is blocked in 
cells where PKC has been inactivated with bryostatin. 
TPA-mediated loss of K1 mRNA is also blocked in 
cells exposed to cycloheximide or actinomycin D  im- 
plicating a PKC-induced protein factor in this process. 
The loss of K1 mRNA in TPA-treated cultures is the 
result of both a  selective destabilization of K1 tran- 
scripts and a rapid inhibition  of K1 gene transcription. 
In contrast to the dramatic repression of mRNAs typi- 
cal for spinous cell differentiation,  activation of PKC 
concurrently enhances expression of mRNAs and pro- 
teins for the granular  cell markers loricrin and filag- 
grin.  This response does not occur in cells pre-treated 
with bryostatin to inactivate PKC.  Our results suggest 
that PKC is a fundamental  regulator of the coordinate 
changes in keratinocyte gene expression that occur 
during the spinous to granular  cell transition  in 
epidermis. 
T 
HE epidermis provides an essential  barrier between 
organism and environment.  The protective function of 
skin is the result of a tightly regulated differentiation 
program which takes place as keratinocytes leave the basal 
layer and migrate through  the spinous,  granular,  and corni- 
fled layers of the epidermis.  The evolution of a basal cell to 
a terminally differentiated  cornified cell is associated with 
the sequential induction of  a family of  differentiation-specific 
proteins,  both structural  and regulatory,  that are unique to 
keratinocytes.  The early markers keratins K1 and K10 are ex- 
pressed in spinous  cells while late differentiation  markers 
such as loricrin and filaggrin  appear in the granular  layer 
(Roop et al.,  1988; Fuchs,  1990).  Ultimately,  activation  of 
keratinocyte-specific  transglutaminase  results  in  covalent 
cross-linking  of certain proteins (such as loricrin)  to form 
the rigid cornified envelope characteristic  of terminally  dif- 
ferentiated keratinocytes (reviewed in Polakowska and Gold- 
smith,  1991). At the mRNA level, expression  of epidermal 
differentiation markers is rigidly compartmentalized with in- 
duction of certain  genes tightly  coupled to repression  of 
others (Stoler et al.,  1988; Coulombe et al.,  1989; Mehrel 
et al., 1990). For example, the abundance of mRNAs encod- 
ing the basal cell keratins  K5 and K14 is markedly reduced 
in the first spinous layer at a time when induction  of K1 and 
K10 mRNA takes place.  Similarly, there is an abrupt loss of 
K1 and K10 transcripts  as cells leaving the spinous layer be- 
gin expressing  loricrin and ftlaggrin mRNA in the granular 
layer. Elucidating  the mechanism by which these divergent 
effects on gene expression are coordinated remains a central 
problem in understanding  epidermal differentiation. 
Cell culture studies have been useful in identifying factors 
influencing keratinocyte differentiation.  Comparative analy- 
sis of keratinocytes  from human and rodent species indicates 
that terminal differentiation is regulated by specific extracel- 
lular  Ca  2+  concentrations  (Yuspa,  1985).  Cultures  estab- 
lished from newborn mouse epidermis and grown in medium 
with  a  reduced  Ca  2+  concentration  (0.05 raM)  yield  a 
proliferating  population of undifferentiated,  basal cell-like 
keratinocytes (Hermings et al.,  1980).  Raising  Ca  2+ in the 
medium to 0.12 mM triggers terminal  differentiation  which 
resembles this process as it occurs in vivo in many respects: 
the early markers K1 and K10 are detected within  8-24 h; 
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cornified  envelopes  are  assembled  as  a  result  of trans- 
glutaminase  activation  (Yuspa et al.,  1989).  Induction  of 
mRNA for the late markers loricrin and filaggrin is coupled 
to reduced expression of transcripts for the early markers K1 
and K10 (Yuspa et al.,  1989), suggesting that Ca  2§ may sig- 
nal both positive and negative modulation of keratinocyte- 
specific gene expression. One change that is not observed in 
vitro is the down modulation of K14 expression that takes 
place in differentiating keratinocytes in vivo: this keratin is 
expressed constitutively in cultured keratinocytes.  A  rela- 
tionship between elevated Ca  2§ and keratinocyte differentia- 
tion is observed both in vitro and in vivo, where a Ca  2§ gra- 
dient has been documented in both human (Malmquist et al., 
1984;  Menon and Elias,  1991)  and mouse (Menon et al., 
1985) epidermis,  with higher  Ca  2§ levels in differentiated 
cell layers than the undifferentiated basal layer. In light of 
these findings  it appears likely that a  Ca2§  sig- 
nailing pathway is involved in the regulation of keratinocyte 
differentiation. 
There is a large body of evidence linking the phospholi- 
pase C-protein kinase  C  (PKC) ~ signal transduction  path- 
way to keratinocyte differentiation.  In cultured mammalian 
keratinocytes,  raising  extracellular  Ca  2§ induces  phospha- 
tidylinositol-specific phospholipase  C  "y and ~ (K.  Punno- 
nen, M. E  Denning,  E. Lee, L. Li, S. G. Rhee, and S. H. 
Yuspa, manuscript in preparation) and increases the level of 
inositol  phosphates  (Tang  et al.,  1988;  Jaken and  Yuspa, 
1988;  Lee and Yuspa,  1991),  intracellular  Ca  2§ (Kruszew- 
ski et al.,  1991),  and diacylglycerol (Lee and Yuspa,  1991; 
Ziboh et al.,  1984).  Ca  2§ also induces qualitative changes 
in keratinocyte PKC (Dunn et al.,  1985) and alters the sub- 
cellular distribution of PKC activity (Isseroff et al.,  1989). 
Furthermore,  detection of Fos protein specifically in differ- 
entiating keratinocytes in vivo supports the hypothesis that 
PKC is activated during this process (Fisher et al., 1991). Di- 
rect activation of PKC in cultured keratinocytes using 12-O- 
tetradecanoylphorbol-13-acetate  (TPA)  induces  epidermal 
transglutaminase and comified envelope formation, markers 
for the final stage of keratinocyte differentiation  (Yuspa et 
al.,  1982; Parkinson et al.,  1984); in contrast, induction of 
the early markers K1 and K10 is inhibited by TPA (Roop et 
al.,  1987).  A  similar uncoupling of differentiation marker 
expression occurs in vivo: TPA rapidly induces epidermal 
transglutaminase  activity and cornification  but blocks ex- 
pression of the spinous cell markers K1 and K10 (Toftgard 
et al.,  1985;  Molloy and Laskin,  1987; Lichti and Yuspa, 
1988).  The molecular regulation of these seemingly para- 
doxical effects of TPA on keratinocyte differentiation has not 
been addressed previously. 
In light of the in vitro and in vivo observations indicating 
that Ca  2+ signals keratinocyte differentiation, the demonstra- 
tion of Ca2§  changes in the phospholipase C-PKC 
pathway in cultured keratinocytes, and induction of certain 
late keratinocyte markers by direct activation of PKC with 
phorbol esters, we have proposed that the PKC signaling path- 
way plays a central role in regulating keratinocyte differentia- 
tion (Yuspa et al., 1990). We have now tested this hypothesis 
1. Abbreviations used in this paper: GAPDH, glyceraldehyde phosphate de- 
hydrogenase; OAG, l-oleoyl-2-acetylglycerol;  PKC, protein kinase C; TPA, 
12-  O-tetradecanoylphorbo1-13-acetate. 
in vitro by examining the molecular regulation of early and 
late  differentiation  markers  in  cultured  mouse  epidermal 
keratinocytes.  PKC  activation  rapidly  alters  keratinocyte 
gene  expression  at transcriptional  and  posttranscriptional 
levels resulting in enhanced expression of late-stage differen- 
tiation markers coupled to repression of early markers. Our 
findings suggest that PKC is a fundamental regulator of the 
coordinate changes  in gene expression,  both positive and 
negative, which occur during keratinocyte differentiation. 
Materials and Methods 
Reagents 
TPA was obtained from LC Services (Woburn, MA); OAG from Molecular 
Probes (Eugene, OR) and Avanti Polar Lipids (Alabaster, AL); actinomycin 
D from Fluka (Ronkonkoma, NY); and N,N-bis-(2-hydroxyethyl)-2-amino- 
sulfonic acid from Calbiochem-Behring  Corp. (San Diego, CA). Bryostatin 
Coryostatin 1) was kindly provided by Dr. G. Pettit (Arizona State Univer- 
sity, Tempe, AZ), and GF 109203X was a gift from Dr. J. Kirilovsky (Glaxo 
Laboratories, Les Ulis, France). Bryostatin stock was prepared in absolute 
ethanol; other reagents were dissolved in DMSO and stored at -20~  Re- 
agents were added to media just before use. To facilitate dispersal of OAG, 
medium was vortexed at the time of OAG addition. 
Cell Culture 
Primary epidermal keratinocytes  were obtained from newborn BALB/c 
mouse skin as described (Hennings et 81., 1980).  Medium was prepared 
with Eagle's  minimum essential medium (without Ca  2+ and Mg  2+) sup- 
plemented  with  8%  FCS  (Ca  2+  depleted  using chelex resin  [Bio-Rad 
Laboratories, Richmond, CA]) and 0.25 % penicillin-streptomycin  solution 
(Gibco Laboratories, Grand Island, NY). The concentration of Ca  2+ in the 
medium was adjusted by addition of 0.3 M CaCI2 stock. Cells were cul- 
tured in medium with 0.05 mM Ca  2+ to maintain a proliferating population 
of basal cells; terminal differentiation was induced by exposing cultures to 
medium containing 0.12 mM Ca  2+ for 20-36 h (Yuspa et al.,  1989). 
Western Blot Analysis 
For analysis of differentiation markers, cultures were washed once with PBS 
(Ca  2+- and Mg2+-free) and total cell lysates prepared using '~10 ~l/cm  2 of 
lysis buffer (5%  SDS,  20% /5-mercaptoethanol  in 0.25  M  Tris,  pH 6.8) 
(Yuspa et al., 1989). Proteins were separated using an 8.5 % polyacrylamide 
gel and transferred to reinforced nitrocellulose membrane (0.2/~m BA-S 
NC; Schleicher & Schuell, Keene, NH). Filters were incubated with block- 
ing buffer (TBS, pH 7.4, with 5 % milk, 0.1% Tween 20) for 30 min, primary 
antibody for 1-2 h, and secondary antibody for 45 min with several washes 
(TBS, 0.2%  Tween 20) between incubations. Antibodies directed against 
keratinocyte differentiation markers (Yuspa et al., 1989) were diluted in 1% 
gelatin in TBS, secondary antibodies were IgGs conjugated  to HRP used 
at a 1:5,000 dilution (Bio-Rad Laboratories), diluted in 2% milk in TBS. 
Immunoreactive proteins were visualized by enhanced chemiluminescence 
using a commercial kit (Amersham Corp., Arlington Heights,  IL). 
RNA Isolation and Analysis 
Total RNA was isolated by centrifugation through 5.7 M cesium chloride 
(Chlrgwin et al., 1979) and separated in a 1% ngarose gel containing 0.6 M 
formaldehyde  (Davis et al.,  1986).  Northern blot analysis was performed 
essentially  as described (Dlugosz and Yuspa,  1991). To analyze effects on 
mRNA stability, differentiation was induced by a 20-24 h exposure to 0.12 
mM Ca  :+ medium. Reagents were then added directly to cultures and cells 
harvested after an additional 2, 4, and 8 h. Actinomycin D stock solution 
was prepared in DMSO: when used at a final concentration of 0.1 #g/ml, 
incorporation of [3I-I] uridine into TCA-insoluble material was blocked by 
95% in primary mouse keratinocyte cultures (Yuspa et al.,  1980). Tran- 
scripts were identified using the following cDNAs either as purified inserts 
or in plasmid vectors, after labeling with 32p by nick translation: K1, K10, 
K14, and loricrin:3'  non-coding fragments (200-450 bp) (Roop et al., 1983; 
Mehrel et al., 1990); filaggrin, 300-bp fragment of coding sequence (Yuspa 
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ing sequence (Stanton et al.,  1983);  GAPDH, full-length rat eDNA (Fort 
et al., 1985). Transcript levels were quantified using a computing laser den- 
sitometer (Molecular Dynamics, Sunnyvale,  CA). 
Nuclear Run-On Analysis 
Gent transcription was examined by in vitro elongation of nascent tran- 
scripts as previously  described (Greenberg and Ziff,  1984),  with minor 
modifications.  Briefly, nuclei were isolated from primary keratinocytes  by 
lysis in buffer containing  10 mM  Tris,  pH  7.4,  10 mM  NaCI,  3  mM 
MgC12, and 0.5%  NP-40.  Nuclear preparations were  frozen  in storage 
buffer (50 mM Tris,  pH  8.3,  5  mM MgC12, 0.1  mM EDTA,  and 40% 
glycerol)  and stored at -70  ~ until use.  Nuclei were thawed on ice and in- 
cubated with an equal volume of 2￿  reaction buffer (10 mM Tris, pH 8.0, 
5 mM MgC12, 0.3 M KC1, 200 U/ml RNAsin)  (Promega,  Madison, WI); 
500  #M  ATP, CTP,  GTP,  10  #M  UTP,  and  200  #Ci  32p-UTP  (800 
Ci/mmol, New England Nuclear, Boston, MA), at 30  ~ for 30 rain. Labeled 
transcripts were  isolated by ultracentrifugation through cesium chloride 
(Chirgwin et al., 1979) and an equal number of counts per minute was hy- 
bridized for 1.5--4 d at 42~  to nitrocellulose-immobilized plasmids, de-- 
scribed above for Northern analysis. 
1~I-EGF  Binding Assay 
Binding of  125I-labeled EGF  was  determined  as  previously  described 
(Stdeldand et al.,  1984), with minor modifications.  Briefly, primary kera- 
tinocytes were grown in 12-well cluster dishes (Costar, Cambridge, MA) 
at an initial density of 5 x  105 eells/ml/well.  After treatment for 1 h, cells 
were washed twice with binding buffer (DME with 50 mM N,N-bis-[2- 
hydroxyethyl]-2-aminosulfonic  acid, pH 7.4, and 1 mg/ml BSA) at 4"C, and 
then incubated with 125I-EGF (0.1 #Ci/ml/well; New England Nuclear) + 
excess-unlabeled  EGF (1 #g/ml, receptor grade; Collaborative Research, 
Bedford,MA) in 1 ml of  binding buffer for 5 h on a bed of ice. Binding buffer 
containing radiolabelled EGF was  removed,  cultures washed four times 
with ice-cold binding buffer and cells harvested in two 500-#1 vol of lysis 
buffer (0.I  M Tris, pH 7.4, 0.5%  SDS,  1 mM EDTA).  Radioactivity  was 
determined by scintillation counting; correction for non-specific  binding 
(usually less than 5% of total counts in control wells) was based on counts 
from cultures  incubated with excess-unlabeled  EGF  (Stricldand et al., 
1984). 
Results 
TPA Blocks Ca2+-mediated Induction of the Early 
Differentiation Markers K1 and KIO 
To explore the role of PKC in keratinocyte differentiation we 
used activators and inhibitors of PKC in conjunction with 
changes in extracellular Ca  ~+ (to trigger terminal differenti- 
ation). We first studied the effect of TPA on Ca2+-mediated 
induction of  Kl and K10 protein: these are the first differenti- 
ation markers to appear after cells leave the basal layer, and 
are expressed throughout the spinous layer of the epidermis. 
TPA blocks Ca2§  accumulation of both KI and 
KI0 in primary keratinocyte cultures but has little effect on 
the level of K14, a basal-cell keratin constitutively expressed 
in vitro (Fig.  1). The ability of TPA to block expression of 
the early markers K1 and K10 is in striking contrast to its 
potency at inducing two markers for a late stage of keratino- 
cyte differentiation, transglutaminase activity and cornified 
envelopes (Yuspa et al.,  1980, 1982). 
PKC Activation Inhibits Ca2+-mediated Induction 
of  Kl mRNA 
K1 was selected to further illustrate TP~s inhibitory effect 
on spinous-cell marker expression at the molecular level. 
Two processes were examined in vitro: Ca2§  ac- 
cumulation of K1 mRNA, which occurs in vivo during the 
Figure L  TPA blocks Ca  2+- 
mediated induction of the spi- 
nous cell differentiation  mark- 
ers  K1  and  KI0. Basal cell 
keratinocyte  cultures were 
grown in medium with 0.05 
mM Ca2+; terminal differenti- 
ation was induced by exposure 
to  0.12 mM  Ca  2+  medium, 
•  nM TPA, for 36 h. West- 
em blot analysis  was performed 
on total cell lysates using anti- 
bodies to the differentiation- 
specific keratim K1 and K10 
and the basal cell keratin K14. 
Similar results were obtained 
in  two  independent experi- 
ments. 
transition from a basal cell to spinous cell phenotype; and 
Ca2+-dependent  maintenance  (Yuspa  et  al.,  1989)  of K1 
mRNA expression, characteristic of all spinous cells. Based 
on Northern blot analysis, TPA blocks Ca2+-mediated  ac- 
cumulation  of K1  mRNA  in  a  dose-dependent  manner. 
Nearly complete suppression of K1  mRNA occurs in the 
presence of 10 nM TPA, with undetectable levels at 100 nM 
TPA and higher (Fig. 2 A).  Similar results were obtained 
for K10 (data not shown).  Ca2+-mediated accumulation of 
K1  mRNA is also blocked by the synthetic diacylglycerol 
1-oleoyl-2-acetylglycerol (OAG;  Fig.  2  B)  suggesting that 
this response to TPA is the result of PKC activation. The ab- 
sence of K1 mRNA does not reflect a general inhibition of 
gene expression since the level of K14 and GAPDH tran- 
scripts is relatively unaffected by TPA (Fig. 2). 
To further substantiate the relationship between PKC acti- 
vation and inhibition of K1 mRNA expression, we compared 
TPA dose-response profiles for both of these responses in 
cultured  keratinocytes.  Since  TPA  rapidly  decreases  the 
affinity  of EGF for its receptor (Schlessinger, 1986), quanti- 
tation of 1z~I-EGF binding provides a measure of PKC acti- 
vation in intact cells. TPA activates PKC in cultured ker- 
atinocytes in a dose-dependent manner, reducing t:SI-EGF 
binding by '~30% at a dose of 1 nM and >75% at doses of 
10 nM or higher (Fig. 3 A). In the same experiment 125 #M 
OAG reduced  ~I-EGF binding by 55%  (Fig.  3 A),  con- 
firming this agent's ability to activate PKC in cultured kera- 
tinocytes. The dose response for TPA-mediated inhibition of 
lzSI-EGF binding and inhibition of K1  mRNA expression 
are similar (Figs. 2 A and 3 A), consistent with the hypothesis 
that K1 mRNA is down modulated as a result of PKC acti- 
vation. 
To further test the hypothesis that activation of PKC in- 
hibits Ca2+-mediated accumulation of ILl mRNA, keratino- 
cytes were rendered functionally deficient in PKC by ex- 
posure to bryostatin, a macrocyclic lactone isolated from the 
primitive marine organism Bugula neritina (Pettit et al., 
1982).  Bryostatin binds and transiently activates PKC but 
subsequently functions as a potent PKC antagonist, blocking 
phorbol ester-induced responses in a variety of cell types in- 
eluding keratinocytes (Sako et al., 1987; Jetten et al., 1989; 
Gsehwendt et al.,  1988).  In cultures pre-treated with bryo- 
statin for 6 h, TPA is completely ineffective in down regulat- 
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mRNA.  Terminal differentiation was induced by growing cells in 
0.12 mM Ca  2+ medium for 24 h, +  PKC activators. (A) Cells were 
exposed to TPA at the  indicated concentrations.  (B)  Cells  were 
treated with 10 nM TPA or 125 #M OAG; bryostatin (60 nM) was 
added to cultures at the same time as DMSO or TPA. Two-indepen- 
dent experiments yielded similar results. 
ing  '25I-EGF  binding  (Fig.  3  B).  Similarly,  bryostatin 
blocks the inhibitory effect of TPA on K1 mRNA expression 
(Fig. 2 B). Combined, these data suggest that both TPA and 
OAG inhibit Ca2+-mediated accumulation of K1 mRNA by 
activating PKC. 
Activation of  PKC Blocks I0 mRNA Expression  in 
Differentiating  Keratinocytes 
In an earlier study from this laboratory, K1 mRNA was rap- 
idly depleted in mouse skin following application of TPA 
(Toftgard et al., 1985), suggesting that activation of the PKC 
pathway can influence the maintenance of K1 expression in 
differentiating spinous cells. To study the molecular basis for 
this response, differentiation was induced in vitro by growing 
primary keratinocytes in 0.12 mM Ca  2+ medium for 20 h. 
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Figure 3. Activation of PKC inhibits ~25I-EGF  binding in differen- 
tiating keratinocytes. (.4) Primary cultures were exposed to TPA or 
OAG at the indicated concentrations  for 1 h; control cultures re- 
ceived 0.1% DMSO. (B) Inactivation of  PKC with bryostatin blocks 
TP/~s effect on ~UI-EGF binding.  Cultures  were pre-treated  with 
60 nM bryostatin for 6 h before the addition of TPA (100 nM). In 
both experiments, cells were grown in 0.12 mM Ca  2+ medium for 
20 h before treatment with TPA or OAG. Similar results were ob- 
tained in additional experiments performed in 0.05 mM Ca  2§ me- 
dium.  Data points are means from triplicate  dishes,  +SEM. 
Cultures were then exposed to reagents for an additional 8 h 
and total RNA isolated for Northern blot analysis. At doses 
>~10 nM TPA markedly reduces the steady-state level of K1 
mRNA in differentiating keratinocytes; in contrast, there is 
little  change  in  the  level  of mRNAs  encoding  K14  and 
GAPDH (Fig. 4 A). The loss of K1 mRNA is coupled to a 
similar  reduction  in  K10  mRNA  (data  not  shown).  K1 
mRNA is also reduced in differentiating keratinocytes ex- 
posed to OAG (Fig. 4 B), suggesting that this response oc- 
curs as a result of PKC activation. Additional support for this 
hypothesis is provided by the observation that TPA fails to 
inhibit K1 mRNA expression in differentiating keratinocytes 
treated with bryostatin to inactivate PKC (Fig. 4  C). 
Inhibition of  K1 mRNA Expression by TPA Requires 
Protein and RNA Synthesis 
Cultures  were treated with metabolic inhibitors to further 
The Journal of Cell Biology, Volume 120,  1993  220 Figure 4. PKC activation  selec- 
tively represses K1 mRNA in 
differentiating  keratinocytes. 
Terminal  differentiation  was 
induced by growing cultures 
in  medium  with  0.12 mM 
Ca  2§ for 20-24 h; PKC acti- 
vators were added for an addi- 
tional 8 h and total RNA iso- 
lated.  (A)  TPA  blocks  K1 
mRNA expression in a dose- 
dependent  manner. (B)  The 
PKC activator OAG (125/zM) 
blocks K1 mRNA expression; 
TPA was used at a concentra- 
tion of 50 nM. (The slower mobility of the K1 band in the fourth lane appears to be a running artifact since it was not detected in other 
northerns from OAG-treated cultures.) (C) Inactivation of PKC with bryostatin blocks TP/~s effect on K1 expression. Cultures were pre- 
treated with 60 nM bryostatin for 6 h to inactivate PKC; TPA concentration was 100 nM. Similar results were obtained in two independent 
experiments. 
characterize the  mechanism  by  which  TPA  represses  K1 
mRNA. Exposure of differentiating keratinocytes to cyclo- 
heximide or actinomycin D alone results in reduced steady- 
state levels of K1 mRNA (Fig. 5), consistent with the pro- 
posed requirement for a  protein factor in Ca2+-dependent 
expression of this transcript (Yuspa et al., 1989). In cultures 
treated with either inhibitor, TPA fails to further reduce the 
level of K1 mRNA; in contrast, there is a marked reduction 
of K1 mRNA in control cultures exposed to TPA alone (Fig. 
5). These results indicate that TPA-mediated down-modula- 
tion of K1 mRNA in differentiating keratinocytes is depen- 
dent on protein and RNA synthesis. 
Activation of  PKC Selectively Reduces K1 mRNA 
Stability and Gene Transcription 
Since transcripts encoding structural proteins generally have 
a long half-life (Medford et al.,  1983) the rapid loss of K1 
Figure 5. Down-modulation of 
K1  mRNA  by TPA requires 
protein  and  RNA  synthesis. 
Differentiating keratinocytes, 
grown in 0.12 mM Ca  2+ me- 
dium for 24 h, were exposed 
to the indicated agents for an 
additional 8 h and total RNA 
isolated.  TPA was used at a 
concentration of 100 nM; cy- 
cloheximide at 20/~g/ml;  ac- 
tinomycin  D  at  0.1  #g/mL 
mRNA was separated in a 1% 
agarose  gel  and  uniformity 
of RNA loading confirmed by 
staining  with  ethidium  bro- 
mide.  Intensity  of  the  K1 
mRNA  signals  was  determined 
by laser densitometry and val- 
ues normalized to the DMSO- 
treated control (100%). 
mRNA in response to TPA suggested an effect on transcript 
stability.  To test this possibility RNA was  analyzed from 
differentiating keratinocytes treated with DMSO, actinomy- 
cin D, or TPA for 2, 4, and 8 h. The short-lived c-myc tran- 
script was undetectable after a 2-h exposure to actinomycin 
D (data not shown), indicating that transcription was effec- 
tively  blocked.  The  steady-state  level  of  K1,  K14,  and 
GAPDH transcripts was slightly reduced in control (DMSO- 
treated) cultures during the course of this experiment (Fig. 
6).  In  cultures  treated with  actinomycin D  for  8  h,  K1 
mRNA  was reduced by 54%  (Fig.  6  B).  The loss of K1 
mRNA was much more rapid in TPA-treated cultures: after 
a 4-h exposure, transcript abundance was reduced to 18 % of 
the initial level with a further reduction to 8 % at 8 h (Fig. 
6 B). These findings suggest that activation of PKC destabi- 
lizes K1 transcripts. Since actinomycin D blocked TP,  gs in- 
hibitory effect on K1 mRNA expression (Fig. 5), the actual 
half-life of  KI transcripts could not be determined by concur- 
rent exposure to both agents and may be even shorter than 
indicated in Fig. 6. The reduction of K1 mRNA stability by 
TPA appears to be selective: K14 transcript levels were not 
reduced relative to controls while  the effect on GAPDH 
abundance was modest (Fig. 6 B). These findings indicate 
that the rapid loss of K1 transcripts in TPA-treated keratino- 
cytes occurs at least partly through a reduction of K1 mRNA 
stability. 
Nuclear  run-on  analysis  was  performed  to  determine 
whether TPA also influences the transcription rate of the K1 
gene. DMSO or TPA was added to cultures of  differentiating 
keratinocytes, nuclei were isolated and nascent transcripts 
elongated in vitro (Greenberg and Ziff,  1984).  A  2-h ex- 
posure to TPA resulted in nearly complete inhibition of K1 
gene transcription; in contrast, GAPDH and K14 transcrip- 
tion rates were relatively unaffected by TPA (Fig. 7). Com- 
bined, the results of these experiments indicate that PKC 
activation rapidly blocks K1  mRNA  expression in differ- 
entiating keratinocytes by selectively reducing both K1 gene 
transcription and KI mRNA stability. 
PKC Mediates Induction of  Late Markers of 
Keratinocyte  Differentiation 
The loss of  K1 and K10 mRNA in cells treated with PKC acti- 
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duces K1  transcript  stability. 
(A)  Northern  blot  analysis. 
(B)  Transcript  levels  quanti- 
fied  by  densitometric  anal- 
ysis: (o) 0.1% DMSO; (zx) 0.5 
#g/ml  actinomycin-D;  (n) 
100  nM  TPA.  Agents  were 
added directly to cultures  of 
differentiating  keratinocytes 
and cells  were harvested  for 
RNA isolation  at the time of 
additions  (t  =  0),  and again 
after 2,  4,  and  8  h  of treat- 
ment.  Only 8 % of the initial 
level (t =  0) of K1 mRNA re- 
mained after an 8-h exposure 
to TPA, while 46% remained 
in cultures treated with actino- 
mycin D. Similar  results were 
obtained  in two  independent 
experiments. 
vators mimics the changes seen in spinous cell markers dur- 
ing the transition to the granular cell phenotype. The follow- 
ing  experiments  were  designed  to  determine  if the  same 
signal could regulate induction of granular cell markers dur- 
ing this transition. Both loricrin and filaggrin are induced in 
vitro  when  keratinocytes  are  grown  in  0.12  mM  Ca  2§ 
medium for 36 h; exposure to OAG further enhances expres- 
sion of these markers (Fig.  8).  Bryostatin blocks induction 
of loricrin and filaggrin in the presence or absence of OAG 
(Fig.  8),  and  the  selective  PKC  inhibitor  GF  109203X 
(Toullec et al.,  1991)  also inhibits  Ca2+-dependent expres- 
sion of both proteins (A. A. Dlugosz, A. Dharia, and S. H. 
Yuspa,  manuscript  in  preparation).  These  results  suggest 
that  PKC  is  required  for Ca2+-mediated  induction of lori- 
crin  and  filaggrin,  as  well  as  the  enhanced  expression  of 
these granular  cell markers by OAG.  Surprisingly,  the ex- 
pression of loricrin and filaggrin protein was not enhanced 
in cultures exposed to TPA and at certain doses was inhib- 
ited  (data  not  shown).  This  may  be  related  to  extremely 
efficient induction of transglutaminase  and cornified enve- 
lopes by TPA with cross-linked proteins being highly insolu- 
ble (Mehrel  et al.,  1990). 
Northern  blot  analysis  was  performed  to  examine  the 
effects  of OAG  and  TPA on  granular  cell  markers  at  the 
Figure  7.  TPA selectively  re- 
presses KI gene transcription. 
Nuclei  were  isolated  from 
differentiating  keratinocytes, 
grown in 0.12 mM Ca  2+ me- 
dium for 20 h, that had been 
exposed to 0.1% DMSO (con- 
trol) or 100 nM TPA for an ad- 
ditional  2  h.  Nascent  tran- 
scripts were elongated in vitro 
and hybridized for 2.5 d at 42~  to the indicated  cDNAs immobi- 
lized on nitrocellulose,  pGEM represents  pGEM 7Zf(+) plasmid 
DNA used as a negative control. Final wash stringency  was 0.2x 
SSC, 0.1% SDS at 65~  followed by treatment with 5 #g/ml RNAse A 
in 2x SSC, (37~  45 min) before autoradiography.  Similar results 
were obtained after TPA exposures  of three and four hours in two 
additional  experiments. 
Figure  8.  Ca2+-mediated  in- 
duction of  loricrin and filaggrin 
is  PKC  dependent.  Primary 
keratinocytes  were  grown in 
0.12  mM  Ca  2+  medium  for 
36 h with the indicated  addi- 
tions  and  total  cell  lysates 
analyzed by western blotting. 
Non-adjacent  lanes  from  a 
single blot were combined to 
produce this  figure. The con- 
centration  of OAG  was  125 
/~M; bryostatin 60 nM. Ca  2+- 
mediated  expression  of lori- 
crin and filaggrin was blocked 
by bryostatin and enhanced by 
OAG in two independent  ex- 
periments. 
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hances  expression  of mRNA 
encoding  the  granular  cell 
differentiation  markers  lori- 
crin  and  filaggrin.  Primary 
keratinocytes were cultured in 
0.12 mM Ca  2+ medium for 24 
h  with  the  indicated  agents. 
TPA  concentration  was  10 
nM, OAG 125/~M, and bryo- 
statin 60 nM. Control cultures 
contain  low levels of mRNA 
for both markers at this rela- 
tively early time point follow- 
ing  Ca  2+  shift.  Expression 
of  loricrin  and/or  filaggrin 
mRNA was enhanced by OAG 
or TPA in two separate experi- 
ments. 
mRNA level.  In cells exposed to 0.12 mM Ca  2§ for 24 h, 
OAG caused a striking increase in loricrin mRNA, while 10 
nM TPA induced a modest enhancement relative to controls 
(Fig.  9 A). Expression of fdaggrin transcripts  was also en- 
hanced by activation of PKC, and in this case OAG and TPA 
elicited similar increases (Fig. 9 B). Bryostatin blocked the 
enhanced  expression  of both  granular  cell  mRNAs  (Fig. 
9).  Along  with  our  findings  at the protein  level  (Fig.  8), 
these results  strongly  implicate  PKC activation  in the up- 
regulation of loricrin and filaggrin gene expression. In sum- 
mary,  our data  indicate that  activation  of PKC  can  coor- 
dinately repress the spinous cell markers K1 and K10 while 
at the same time inducing the granular cell markers loricrin 
and filaggrin. 
Discussion 
Keratinocyte differentiation is induced in vitro by exposure 
to specific extracellular  Ca  2+ concentrations  (Yuspa et al., 
1989),  and  the  correlation  between  differentiation  and 
elevated Ca  2+ in mammalian  epidermis  (Menon  and Elias, 
1991; Menon et al.,  1985; Malmquist et al.,  1984) suggests 
that  this  ion  also  regulates  keratinocyte  differentiation  in 
vivo.  The,recent  finding that raising  extracellular  Ca  2+ in- 
duces graded increases in phosphatidylinositol metabolism 
and diaeylglycerol levels in cultured keratinocytes (Lee and 
Yuspa,  1991)  suggested  that  PKC  was  activated  during 
Ca2+-mediated differentiation.  In the present study we have 
explored the potential role of PKC as a regulator of keratino- 
cyte differentiation using an in vitro model system. Activa- 
tion of PKC in cultured epidermal keratinocytes results in 
repression of transcripts for the early differentiation markers 
K1  and K10 coupled to induction of mRNAs encoding the 
late markers  loricrin  and filaggrin,  a  phenotype expressed 
by  granular  cells  in  vivo.  These  responses  reflect  PKC- 
mediated changes at transcriptional  and posttranscriptional 
levels. Our findings identify PKC as a fundamental regulator 
of keratinocyte differentiation coordinating both positive and 
negative changes in gene expression which occur at a specific 
stage in this process. 
In  previous  studies  TPA  was reported  to have opposite 
effects on different markers  of keratinocyte differentiation: 
transglutaminase  activity  and  cornification  were  induced 
(Yuspa et al.,  1982; Parkinson et al.,  1984) whereas K1 and 
K10 expression were blocked (Roop et al., 1987; Molloy and 
Laskin,  1987; Toftgard et al.,  1985). These observations are 
entirely consistent with the hypothesis, based on our present 
findings,  that PKC selectively triggers a late stage of kera- 
tinocyte differentiation in which early marker expression is 
actively  repressed.  The  rapid  down-modulation  of  K1 
mRNA by TPA is the result of a selective reduction in K1 
mRNA  stability  (Fig.  6)  and  transcription  (Fig.  7).  Our 
results  strongly  support previous work indicating  that  ex- 
pression of certain keratins is regulated at the posttranscrip- 
tional level (Tyner and Fuchs, 1986). Transcript destabiliza- 
tion  may  be  required  for  the  rapid  disappearance  of K1 
transcripts  in  cells  entering  the  granular  compartment  of 
epidermis  (Roop et  al.,  1988;  Stoler  et  al.,  1988).  TPA 
influences mRNA stability in several other systems, either 
increasing  (Weber et al.,  1989; Wager and Assoian,  1990) 
or decreasing (Saceda et al.,  1991; Brooks et al.,  1991; Choi 
et al.,  1991; Zhu et al.,  1991) transcript half-life. As in this 
report (Fig. 5) a protein factor appears to be involved in sev- 
eral cases. These observations raise the possibility that sus- 
ceptibility  to  TPA-mediated  degradation  (or  stabilization) 
defines a set of transcripts the same way that transcriptional 
activation by TPA defines a  set of genes.  As described for 
other modulators of transcript stability (reviewed in Cleve- 
land and Yen,  1989), mRNAs may contain recognition se- 
quences analogous to TPA-response elements of DNA, with 
distinct protein  factors influencing  transcript  stability.  Ex- 
pression  of mRNAs encoding  functionally  linked proteins 
could thus  be coordinately  regulated  at the posttranscrip- 
tional level.  Cultured murine  epidermal keratinocytes may 
provide a useful model for testing this hypothesis. 
In addition to its effect on K1 mRNA stability, TPA rapidly 
inhibits transcription of the K1 gene (Fig. 7). Potential mech- 
anisms include TPA-mediated inhibition of a transcriptional 
activator or induction of a transcriptional repressor. Consis- 
tent with the first possibility, phosphorylation of myogenin 
by PKC blocks binding to muscle-specific enhancer elements 
(Eric Olson,  University of Texas  M.D.  Anderson Medical 
Center;  personal  communication)  and may be responsible 
for  TPgs  ability  to  inhibit  marker  expression  in  cultured 
myotubes (Choi et ai.,  1991;  Zhu et al.,  1991).  However, 
master regulators  of keratinocyte differentiation  analogous 
to those described for muscle cells have yet to be described. 
Binding of positive-acting  factors to target sequences may 
also be blocked by complex formation with other regulatory 
proteins, as has been reported for AP-1 and the activated glu- 
cocorticoid  or  retinoic  acid  receptors  (Angel  and  Karin, 
1991). Furthermore, protein-protein interactions may inhibit 
transactivation without influencing DNA-binding: this is the 
proposed mechanism by which the adenovirus E1A protein 
blocks AP-l-mediated transcription  (Offringa et al.,  1990). 
Investigation of these possibilities awaits characterization of 
positive-acting  factors involved in K1  expression. 
An alternative mechanism by which TPA could block K1 
transcription is through induction of a transcriptional repres- 
sor. TPA increases c-fos and c-jun mRNA in cultured kera- 
tinocytes (Dotto et al.,  1986) and may elevate the level of 
AP-1,  which  can  function  as  a  transcriptional  repressor 
(Takimoto et al.,  1989; Distel et al.,  1987) in addition to its 
well-characterized role as a transcriptional  activator (Angel 
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tion independent of AP-1 by binding to CArG elements (Gius 
et al.,  1990). Analysis of regulatory sequences located 3' to 
the human K1 gene has revealed an AP-I site at nucleotides 
224-230 ((2. A. Huff, S. H. Yuspa, and D. Rosenthal, manu- 
script in press) but the functional significance of this element 
has not been established. A role for AP-1 as a positive regula- 
tor of keratin expression has, however, been reported:  the 
first intron of the human K18 gene contains a functional AP-1 
site (Oshima et al.,  1990). 
AP-2 binding sites have been reported upstream of the hu- 
man KS, K14, K1, and K6b genes, and in the case of K14 this 
element appears to be necessary, although not sufficient, for 
gene expression (Leask et al.,  1990,  1991).  Factors which 
bind to these sites have been detected in a restricted number 
of tissues and cell types, including mouse, human, and Xeno- 
pus keratinocytes  (Leask et ai.,  1991; Shape et al.,  1991). 
AP-2 elements may provide additional targets for regulation 
of keratin gene expression by PKC,  since AP-2 activity  is 
elevated in cells treated with TPA, cyclic AMP, or retinoic 
acid (Luseher et al.,  1989; Imagawa et al.,  1987).  Under- 
standing the role of PKC in regulating keratin gene transcrip- 
tion awaits further analysis of relevant cis-acting elements 
and protein factors with which they interact. 
In contrast to the inhibitory effect on K1 and K10, activa- 
tion of PKC enhances expression of loricrin and filaggrin at 
both the mRNA and protein level. Treatment with bryostatin 
blocks the increased  abundance of these transcripts  in re- 
sponse to TPA or OAG as well as their baseline induction by 
Ca  2+, suggesting that expression of granular cell markers is 
a PKC-dependent process. In preliminary experiments, TPA 
did not induce filaggrin mRNA in basal cell keratinocyte cul- 
tures (grown in medium with 0.05  mM  Ca2+), suggesting 
that both Ca  2+ and PKC activation are required for expres- 
sion of this granular cell marker.  Evidence for an obligatory 
role for Ca  2+ was obtained using the intracellular calcium 
chelator  BAPTA,  which  completely  blocks  expression  of 
differentiation markers in cultured murine epidermal kera- 
tinocytes  (L.  Li and S.  H.  Yuspa, unpublished data).  Fur- 
thermore,  Ca2+-sensitive  regulatory  sequences  controlling 
expression  of the human K1  gene  have recently  been  de- 
scribed (C. A. Huff, S. H. Yuspa, and D. Rosenthal, manu- 
script  in  press).  Noteworthy  in  light  of  a  proposed  co- 
requirement for Ca  2+ and PKC in regulating transcription, a 
VL30 enhancer element has recently been described which 
is dependent on Ca  2+ for its responsiveness to TPA or EGF 
(Lenormand et al.,  1992). 
TPA is a less potent inducer of loricrin mRNA than OAG 
while these two agents are equally effective at inducing filag- 
grin transcripts (Fig. 9). These results suggest subtle differ- 
ences  in  the  regulation  of  individual  late  differentiation 
markers  by  PKC.  TPA  and  OAG  have  previously  been 
reported to elicit different responses, both qualitatively and 
quantitatively,  in other cell types (Komorowski and Tsang, 
1990) but the basis for these differences has not been deter- 
mined.  Since PKC consists of a family of isozymes (Stabel 
and Parker,  1991) which appear to have distinct functions 
(Otte and Moon,  1992; Gusovsky and Gutldnd,  1991), one 
potential explanation is selective (or preferential) activation 
of specific PKC isozymes by different activators. Consistent 
with this possibility,  interferon  a  increases  diacylglycerol 
levels in Dandi cells  and activates PKC e but not PKC tx, 
whereas both isoforms are activated by TPA (Pfeffer et al., 
1991). We have recently reported expression of mRNA en- 
coding  PKC  o~,  6,  e,  ~',  and  7/  in  cultured  keratinocytes 
(Dlugosz et ai.,  1992) and the presence of each of these iso- 
forms has been confirmed at the protein level, with the ex- 
ception of PKC e (unpublished data). Experiments aimed at 
defining the role of individual PKC isozymes in keratinocyte 
differentiation are currently underway. 
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